Liquid Biopsy Market is expected to reach USD 4.79 billion by 2028, at a CAGR of 20.2%.

North American region is anticipated to have the highest share of the liquid biopsy market in the forecast period due to the growing awareness about the diagnosis of cancer in this region.

Spread the love

Global Liquid Biopsy Market was valued at USD 1.32 billion in 2021 and is expected to reach USD 4.79 billion by the year 2028, at a CAGR of 20.2%.

 A liquid biopsy is a simple and non-invasive alternative to surgical biopsies that allows doctors to learn about tumors from a simple blood sample.  In 1994, scientists advanced to the point where they could detect specific mutations in cfDNA.

Liquid Biopsy market research includes a thorough competitor study analysis and SWOT analysis. According to the market study, report covers key players market share and global impression through collaborations, mergers and acquisitions, joint ventures, partnerships, agreements and product launches. The research examines macroeconomic and microeconomic variables that may affect market demand and growth. The research reports covers COVID-19 impact on  current market position as well as regional analysis for future growth. The market size, share, production, revenue, production, gross margin, pricing, and market-influencing factors are all covered in research report. The market research report is in-depth examined for the relevant time frame.

Read Complete Research @

Liquid Biopsy Market

Leading Key Players:

  • F. Hoffmann-La Roche Ltd. (Switzerland)
  • Myriad Genetics Inc. (US)
  • QIAGEN N.V. (Netherlands)
  • Thermo Fisher Scientific Inc. (the US)
  • Guardant Health Inc. (the US)
  • BIOCEPT Inc. (the US)
  • Illumina Inc. (the US)
  • Angle plc (UK)
  • Oncimmune(UK)
  • Lucence health Inc. (US)
  • FreenomeHoldings Inc. (US) and Other Major Players.

 Download Sample Copy @

Market Dynamics and Factors:


  • Increasing Prevalence of Cancer


  • Liquid Biopsy Isn’t Yet Considered A Typical Testing Procedure


  • The Increasing Importance Of Companion Diagnostics

 Market Segment:

By Cancer Type Lung

  • Breast
  • Liver
  • Others

By Circulating Biomarker             

  • Circulating Tumor DNA
  • Circulating Tumor Cells
  • Others

By End-User      

  • Hospitals
  • Laboratories
  • Government Research Centre

 Customized Research @

Market Segment by Region:

  • North America (U.S., Canada, Mexico)
  • Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
  • Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
  • Middle East & Africa (Turkey, Saudi Arabia, Iran, UAE, Africa, Rest of MEA)
  • South America (Brazil, Argentina, Rest of SA)

Key Industry Development In The Liquid Biopsy Market

In July 2021, Biocept, Inc. was awarded a South Korean Patent for its Primer-Switch technology, which detects rare mutations in circulating tumor DNA (ctDNA) using real-time PCR and associated analysis methods.

In March 2021, Lucence announced a partnership with Waseda University in Japan to develop a unique high-speed liquid biopsy laser-based imaging platform for early cancer detection.

In February 2021, Guardant Health, Inc. announced the supply of Guardant Reveal, the primary blood-only liquid biopsy test for the detection of residual and recurrent disease from an easy blood draw.

 Download Sample Copy @

Key Benefits of Global Market Research Report:

  • Market Segmented by Types, Applications, Regions, and key players
  • Potential Market Drivers. restraints, opportunities and challenges in the study
  • Recent Key industry news, developments and trends
  • Leading Competitive landscape & strategies of industry players
  • Research coves market historical, current, and projected market size and share value
  • In-depth analysis of market in terms of sales, price, revenue, market share, and growth rate
  • Research covers the porter analysis Bargaining Power of Suppliers and consumers, Threats of New Entrants, Substitute Product and Services

About us:

Introspective Market Research ( is a visionary research consulting firm dedicated to assist our clients grow and have a successful impact on the market. Our team at IMR is ready to assist our clients flourish their business by offering strategies to gain success and monopoly in their respective fields. We are a global market research company, specialized in using big data and advanced analytics to show the bigger picture of the market trends. We help our clients to think differently and build better tomorrow for all of us. We are a technology-driven research company, we analyze extremely large sets of data to discover deeper insights and provide conclusive consulting. We not only provide intelligence solutions, but we help our clients in how they can achieve their goals.

Contact us:

Introspective Market Research

3001 S King Drive,

Chicago, Illinois

60616 USA

Ph no: +1-773-382-1047

LinkedIn | Twitter | Facebook

Spread the love

Related Articles

Leave a Reply

Your email address will not be published.

Back to top button